サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226912

中南米の敗血症診断薬市場の2028年までの予測-地域分析- 製品、技術、方法、検査タイプ、病原体、エンドユーザー別

South & Central America Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Technology, Method, Test Type, Pathogen, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 183 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中南米の敗血症診断薬市場の2028年までの予測-地域分析- 製品、技術、方法、検査タイプ、病原体、エンドユーザー別
出版日: 2023年02月24日
発行: The Insight Partners
ページ情報: 英文 183 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の敗血症診断薬市場は、2021年の3,866万米ドルから2028年には6,959万米ドルに成長すると予測されます。2021年から2028年までのCAGRは8.8%を記録すると推定されています。

院内感染の増加による敗血症の発症率の高さが中南米の敗血症診断薬市場の成長を促進する

感染症は敗血症の根本的な原因です。敗血症は主に、化学療法を受けている人、脾臓を摘出した人、AIDSや糖尿病などの慢性疾患を患っている人など、免疫力が低下している人に起こります。数種類の感染症の中でも、院内感染症は入院患者の罹患率と死亡率の主な原因となっています。早期診断と適切な臨床管理により、ほとんどの死亡を防ぐことができます。これらの死亡は、多くの場合、下痢性疾患や下気道感染症の結果です。このように、敗血症の発生率の高さは、敗血症診断製品の需要を押し上げ、予測期間中の中南米の敗血症診断薬市場の成長をサポートすると期待されます。

中南米の敗血症診断薬市場の概要

中南米の敗血症診断薬市場は、アルゼンチン、ブラジル、その他南米に区分されます。同地域の市場成長は、同地域における高齢化率の上昇と敗血症患者の負担増に起因しています。

中南米敗血症診断薬市場の収益と2028年までの予測（百万米ドル）

中南米の敗血症診断薬市場のセグメンテーション

中南米の敗血症診断薬市場は、製品、技術、方法、検査タイプ、病原体、エンドユーザー、国に基づいてセグメント化されます。

製品に基づき、中南米の敗血症診断薬市場は、機器、試薬およびアッセイ、血液培養液、ソフトウェアに区分されます。2021年には、血液培養液セグメントが最大の市場シェアを占めています。

技術に基づき、中南米の敗血症診断薬市場は、分子診断、フローサイトメトリー、マイクロフルイディクス、イムノアッセイ、バイオマーカー、微生物学にセグメント化されます。2021年には微生物学分野が最大の市場シェアを占めています。分子診断分野の市場は、ポリメラーゼ連鎖反応、ペプチド核酸-蛍光in situハイブリダイゼーション、シンドロームパネルベース検査、マイクロアレイにサブセグメント化されています。

手法に基づき、中南米の敗血症診断薬市場は自動診断薬と従来型診断薬に二分されます。2021年には、従来型診断法がより大きな市場シェアを占めています。

検査タイプに基づき、中南米の敗血症診断薬市場はポイントオブケア検査とラボラトリー検査に二分されます。2021年はラボラトリーテスト部門がより大きな市場シェアを占めています。

病原体に基づき、中南米の敗血症診断薬市場は、細菌性敗血症、真菌性敗血症、その他に区分されます。2021年には細菌性敗血症セグメントが最も大きな市場シェアを占めています。

エンドユーザーに基づき、中南米の敗血症診断薬市場は、病院、病理学およびリファレンスラボラトリー、その他に区分されます。2021年には病院セグメントが最大の市場シェアを占めています。

国別に見ると、中南米の敗血症診断薬市場は、ブラジル、アルゼンチン、その他南米に区分されます。2021年の市場シェアは、ブラジルが独占しました。

Abbott、BD、bioMerieux SA、Danaher（Beckman Coulter）、F. HOFFMANN-LA ROCHE LTD.、THERMO FISHER SCIENTIFIC INC.などは、南中米の敗血症診断薬市場で活動している主要企業です。

目次

第1章 イントロダクション

  • 本調査の対象範囲
  • 洞察パートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • 中南米の敗血症診断薬市場- 製品別
    • 中南米の敗血症診断薬市場- 技術別
    • 中南米の敗血症診断薬市場- 方法別
    • 中南米の敗血症診断薬市場- 検査タイプ別
    • 中南米の敗血症診断薬市場- 病原菌別
    • 中南米の敗血症診断薬市場- エンドユーザー別
    • 中南米の敗血症診断薬市場- 国別

第2章 主要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 中南米の敗血症診断薬市場- 市場情勢

  • 中南米のPEST分析
  • 専門家の見解

第5章 中南米の敗血症診断薬市場- 主要な市場力学

  • 市場促進要因
    • 院内感染の増加別敗血症の発生率の上昇
    • 迅速な診断テストに対する需要の高まり別製品発売の増加
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • 敗血症診断薬研究のための資金調達と支援の増加
  • 今後の動向
    • 敗血症診断における技術的進歩の高まり
  • 影響度分析

第6章 敗血症診断薬市場-南米・中米の分析

  • 中南米の敗血症診断薬市場収益と予測・分析

第7章 中南米の敗血症診断薬市場の収益と2028年までの予測-製品別

  • 中南米の敗血症診断薬市場、製品別、2021年・2028年（%）
  • インストゥルメント
  • 試薬およびアッセイ
  • 血液培養培地
  • ソフトウェア

第8章 敗血症診断薬市場の収益と2028年までの予測- 技術編

  • 中南米の敗血症診断薬市場の技術別シェア-2021年・2028年（%）
  • 分子診断薬
      • ポリメラーゼ連鎖反応
      • ペプチド核酸-蛍光インサイチュハイブリダイゼーション
      • シンドロミックパネルベースの検査
      • マイクロアレイ
  • フローサイトメトリー
    • リアルタイムの細胞解析
      • TaqMan-Based Multiplex RT PCRと血液培養
      • レジーナ・マルゲリータ小児病院（イタリア、トリノ）で実施されたMagicplex（TM）Sepsis Real-Time Tests-ケーススタディ
      • 敗血症診断ソリューションの提供を手がける企業
      • リアルタイムPCR別敗血症診断
      • 次世代シーケンサーの新手法と技術の進歩・革新
      • インピーダンス測定別リアルタイム細胞解析
  • マイクロフルイディクス
  • イムノアッセイ
  • バイオマーカー
    • メタボロミクス
      • 敗血症におけるメタボロームプロファイル
      • 敗血症診断におけるメタボロミクスの普及・利用形態
      • メタボロームプロファイリング別敗血症の早期予知
      • 敗血症の診断と治療におけるオミクスの今後の役割
      • 敗血症のバイオマーカーと診断ツール
      • 敗血症におけるメタボロミクスとプロテオミクスの役割
      • 急性腎不全の予後を予測する低分子バイオマーカー同定のためのアプローチとして期待されるもの
      • 敗血症診断におけるメタボロミクスの最新応用例
      • ミトコンドリア機能におけるメタボロミクス
      • ミトコンドリア医学の診断におけるメタボロミクスの大きな可能性
  • 微生物学

第9章 中南米敗血症診断薬市場の収益と2028年までの予測- 方法編

  • 中南米の敗血症診断薬市場のメソッド別シェア-2021年・2028年（%）
  • 自動化された診断法
  • 従来型診断法

第10章 中南米の敗血症診断薬市場の収益と2028年までの予測（検査タイプ別

  • 中南米の敗血症診断薬市場：検査タイプ別シェア（2021年・2028年）（%）
  • ポイントオブケア検査
  • ラボラトリー検査

第11章 中南米の敗血症診断薬市場の収益と2028年までの予測- 病原菌編

  • 中南米の敗血症診断薬市場：病原体別シェア-2021年・2028年（%）
  • 細菌性敗血症
  • 真菌性敗血症
  • その他

第12章 中南米敗血症診断薬市場の収益と2028年までの予測（エンドユーザー編

  • 中南米の敗血症診断薬市場のエンドユーザー別シェア（2021年・2028年）（%）
  • 病院
    • 病院
  • 病理学およびリファレンスラボラトリー
  • その他

第13章 中南米の敗血症診断薬市場の収益と2028年までの予測- 国別分析

      • ブラジル
      • その他中南米地域

第14章 敗血症診断薬市場-業界情勢

  • 敗血症診断薬市場における成長戦略（%）
  • 有機的な展開
  • 無機的な開発

第15章 企業プロファイル

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • BD
  • Danaher（Beckman Coulter）
  • THERMO FISHER SCIENTIFIC INC.
  • bioMerieux SA

第16章 企業プロファイル付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. New next-generation sequencing techniques by Company
  • Table 2. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 3. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 4. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 5. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 6. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 7. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 8. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 9. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 10. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 11. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 12. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 13. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 14. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 15. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 16. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 17. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 18. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 19. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 20. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 21. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 22. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 23. Recent Organic Growth Strategies in Sepsis Diagnostics Market
  • Table 24. Inorganic Developments in the Sepsis Diagnostics Market
  • Table 25. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Sepsis Diagnostics Market Segmentation
  • Figure 2. South & Central America Sepsis Diagnostics Market, By Country
  • Figure 3. South & Central America Sepsis Diagnostics Market Overview
  • Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in South & Central America Sepsis Diagnostics Market
  • Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. South & Central America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. South & Central America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
  • Figure 11. Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 12. Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13. Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 14. Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 15. South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • Figure 16. Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 17. Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 19. Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 20. Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 21. Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 22. Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 23. Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 24. Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 25. Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 26. Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 27. Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 28. South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • Figure 29. Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 30. Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • Figure 32. Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • Figure 35. Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36. Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 37. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 38. South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • Figure 39. Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 40. Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 41. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 42. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
  • Figure 43. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 44. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 45. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 46. Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
  • Figure 47. Growth Strategies in the Sepsis Diagnostics Market (%)
目次
Product Code: BMIRE00028086

The South & Central America sepsis diagnostics market is expected to grow from US$ 38.66 million in 2021 to US$ 69.59 million by 2028. It is estimated to record a CAGR of 8.8% from 2021 to 2028.

High Incidence of Sepsis due to Increasing Nosocomial Infections Fuels South & Central America Sepsis Diagnostics Market Growth

Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the South & Central America sepsis diagnostics market growth during the forecast period.

South & Central America Sepsis Diagnostics Market Overview

The South & Central America sepsis diagnostics market is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the rising aging population and increasing burden of sepsis cases in the region.

South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Sepsis Diagnostics Market Segmentation

The South & Central America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.

Based on product, the South & Central America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the South & Central America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the South & Central America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the South & Central America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the South & Central America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the South & Central America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the South & Central America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2021.

Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the South & Central America sepsis diagnostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America sepsis diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Sepsis Diagnostics Market - By Product
    • 1.3.2 South & Central America Sepsis Diagnostics Market - By Technology
    • 1.3.3 South & Central America Sepsis Diagnostics Market - By Method
    • 1.3.4 South & Central America Sepsis Diagnostics Market - By Test Type
    • 1.3.5 South & Central America Sepsis Diagnostics Market - By Pathogen
    • 1.3.6 South & Central America Sepsis Diagnostics Market - By End User
    • 1.3.7 South & Central America Sepsis Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Sepsis Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. South & Central America Sepsis Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
    • 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
  • 5.4 Future Trends
    • 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
  • 5.5 Impact Analysis

6. Sepsis Diagnostics Market- South & Central America Analysis

  • 6.1 South & Central America Sepsis Diagnostics Market Revenue Forecast and Analysis

7. South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

  • 7.1 Overview
  • 7.2 South & Central America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.4 Reagents and Assays
    • 7.4.1 Overview
    • 7.4.2 Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.5 Blood Culture Media
    • 7.5.1 Overview
    • 7.5.2 Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.6 Software
    • 7.6.1 Overview
    • 7.6.2 Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

  • 8.1 Overview
  • 8.2 South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • 8.3 Molecular Diagnostics
    • 8.3.1 Overview
    • 8.3.2 Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Polymerase Chain Reaction
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Syndromic Panel-Based Testing
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.4 Microarrays
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Flow Cytometry
    • 8.4.1 Overview
    • 8.4.2 Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Real-Time Cell Analysis
      • 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
        • 8.4.3.1.1 Characteristics of TaqMan Assays
      • 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
        • 8.4.3.2.1 Abstract
        • 8.4.3.2.2 Conclusion:
      • 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
      • 8.4.3.4 Sepsis diagnosis by real-time PCR
      • 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
      • 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
    • 8.4.4 Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Microfluidics
    • 8.5.1 Overview
    • 8.5.2 Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Immunoassay
    • 8.6.1 Overview
    • 8.6.2 Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Biomarkers
    • 8.7.1 Overview
    • 8.7.2 Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.7.3 Metabolomics
      • 8.7.3.1 Metabolite Profile in Sepsis
      • 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
      • 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
      • 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
        • 8.7.3.4.1 Genomics
        • 8.7.3.4.2 Proteomics
      • 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
      • 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
      • 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
      • 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
      • 8.7.3.9 Metabolics in Mitochondrial Function
      • 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
    • 8.7.4 Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Microbiology
    • 8.8.1 Overview
    • 8.8.2 Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

  • 9.1 Overview
  • 9.2 South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • 9.3 Automated Diagnostics
    • 9.3.1 Overview
    • 9.3.2 Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Conventional Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

  • 10.1 Overview
  • 10.2 South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • 10.3 Point-of-Care Tests
    • 10.3.1 Overview
    • 10.3.2 Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Laboratory Tests
    • 10.4.1 Overview
    • 10.4.2 Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

  • 11.1 Overview
  • 11.2 South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • 11.3 Bacterial Sepsis
    • 11.3.1 Overview
    • 11.3.2 Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Fungal Sepsis
    • 11.4.1 Overview
    • 11.4.2 Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

  • 12.1 Overview
  • 12.2 South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • 12.3 Hospitals
    • 12.3.1 Overview
    • 12.3.2 Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.4 Pathology and Reference Laboratories
    • 12.4.1 Overview
    • 12.4.2 Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.5 Others
    • 12.5.1 Overview
    • 12.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Country Analysis

  • 13.1 Overview
    • 13.1.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 13.1.2.1 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.1.2.1.1 Overview
        • 13.1.2.1.2 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.1.2.1.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
        • 13.1.2.1.4 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.2.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.2.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.2.1.4.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.2.1.5 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.2.1.6 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.2.1.7 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.2.1.8 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.1.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.1.2.2.1 Overview
        • 13.1.2.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.1.2.2.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
        • 13.1.2.2.4 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.2.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.2.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.2.2.4.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.2.2.5 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.2.2.6 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.2.2.7 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.2.2.8 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.1.2.3 Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
        • 13.1.2.3.1 Overview
        • 13.1.2.3.2 Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
        • 13.1.2.3.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
        • 13.1.2.3.4 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.2.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.2.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.2.3.4.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.2.3.5 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.2.3.6 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.2.3.7 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.2.3.8 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

14. Sepsis Diagnostics Market-Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.4 Inorganic Developments
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Abbott
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 F. HOFFMANN-LA ROCHE LTD.
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 BD
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Danaher (Beckman Coulter)
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 THERMO FISHER SCIENTIFIC INC.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 bioMerieux SA
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments

16. Appendix

  • 16.1 About the Insight Partners
  • 16.2 Glossary of Terms